ATE300874T1 - Transglutaminasehemmer in lebensmittelqualität und seine verwendung - Google Patents

Transglutaminasehemmer in lebensmittelqualität und seine verwendung

Info

Publication number
ATE300874T1
ATE300874T1 AT01992508T AT01992508T ATE300874T1 AT E300874 T1 ATE300874 T1 AT E300874T1 AT 01992508 T AT01992508 T AT 01992508T AT 01992508 T AT01992508 T AT 01992508T AT E300874 T1 ATE300874 T1 AT E300874T1
Authority
AT
Austria
Prior art keywords
food grade
milk
whey
transglutaminase inhibitor
transglutaminase inhibitors
Prior art date
Application number
AT01992508T
Other languages
English (en)
Inventor
Jong Govardus Adrianus Hube De
Johannes Wilhelmus Leo Boumans
Gerrit Wijngaards
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8172197&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE300874(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE300874T1 publication Critical patent/ATE300874T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00—Processes
    • A23V2300/34—Membrane process

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Water Supply & Treatment (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
AT01992508T 2000-10-31 2001-10-30 Transglutaminasehemmer in lebensmittelqualität und seine verwendung ATE300874T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203778A EP1201136A1 (de) 2000-10-31 2000-10-31 Transglutaminasehemmer mit Nahrungsmittelqualitität und Verwendungen davon
PCT/NL2001/000795 WO2002035942A1 (en) 2000-10-31 2001-10-30 Food grade transglutaminase inhibitor and uses thereof

Publications (1)

Publication Number Publication Date
ATE300874T1 true ATE300874T1 (de) 2005-08-15

Family

ID=8172197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01992508T ATE300874T1 (de) 2000-10-31 2001-10-30 Transglutaminasehemmer in lebensmittelqualität und seine verwendung

Country Status (9)

Country Link
US (1) US7491410B2 (de)
EP (2) EP1201136A1 (de)
JP (1) JP2004512344A (de)
AT (1) ATE300874T1 (de)
AU (1) AU2002224202A1 (de)
CA (1) CA2427193A1 (de)
DE (1) DE60112465T2 (de)
NZ (1) NZ526163A (de)
WO (1) WO2002035942A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE505201T1 (de) 2002-02-14 2011-04-15 Univ Leland Stanford Junior Enzymbehandlung von nahrungsmitteln für zöliakie- sprue
US8143210B2 (en) * 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7462688B2 (en) * 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
CA2487247A1 (en) * 2002-05-14 2003-11-27 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7265093B2 (en) * 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
EP1563300B1 (de) 2002-11-20 2012-04-18 The Board Of Trustees Of The Leland Stanford Junior University Diagnoseverfahren für sprue/zöliakie
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
ATE547105T1 (de) * 2005-08-03 2012-03-15 Nat Cancer Ct Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems
WO2008115411A1 (en) * 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
KR20080108797A (ko) * 2007-06-11 2008-12-16 국립암센터 Ｅｇｃｇ를 포함하는 트란스글루타미나제 억제제 및 그의제조방법
FI126431B (fi) * 2011-06-16 2016-11-30 Valio Oy Juusto ja sen valmistus
GB201318182D0 (en) * 2013-10-14 2013-11-27 Univ Nottingham Trent Inhibitor peptides

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198213A (en) * 1985-04-15 1993-03-30 Protein Technology, Inc. Method of disease treatment utilizing an immunologically whey fraction
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
US5098707A (en) 1989-07-31 1992-03-24 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
JP2897780B2 (ja) * 1990-03-09 1999-05-31 ニッピゼラチン工業株式会社 高重合ゼラチンの製造法
DK41892D0 (de) 1992-03-27 1992-03-27 Novo Nordisk As
JP3182954B2 (ja) 1993-01-08 2001-07-03 味の素株式会社 ヨーグルト類の製造法
IT1264084B1 (it) 1993-12-22 1996-09-10 Raggio Italgene Spa Peptide ad attivita' di substrato e/o inibitore dell'enzima transglutaminasi e suo uso in diagnosi e terapia.
JP4509224B2 (ja) * 1996-09-06 2010-07-21 ポール・コーポレーション 剪断分離方法及びシステム
FI104457B (fi) * 1997-04-30 2000-02-15 Valio Oy Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
US6162791A (en) 1998-03-02 2000-12-19 Apotex Inc. Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
WO1999065515A2 (en) * 1998-06-15 1999-12-23 Arch Development Corporation Combination of radiotherapy and anti-angiogenic factors
AU4823999A (en) 1998-06-17 2000-01-05 Yeda Research And Development Co. Ltd. Methods and compositions for treating diseases mediated by transglutaminase activity
EP1140053A1 (de) * 1999-01-05 2001-10-10 Richard J. Bendera Zusammensetzung und methode zur steigerung der männlichen fruchtbarkeit und libido

Also Published As

Publication number Publication date
NZ526163A (en) 2005-03-24
DE60112465D1 (de) 2005-09-08
CA2427193A1 (en) 2002-05-10
AU2002224202A1 (en) 2002-05-15
EP1330166B1 (de) 2005-08-03
EP1201136A1 (de) 2002-05-02
WO2002035942A1 (en) 2002-05-10
DE60112465T2 (de) 2006-06-08
JP2004512344A (ja) 2004-04-22
EP1330166A1 (de) 2003-07-30
US7491410B2 (en) 2009-02-17
US20050031603A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
CY1116039T1 (el) Μεθοδος κλασματωσης γαλακτοκομικων συνθεσεων
ATE300874T1 (de) Transglutaminasehemmer in lebensmittelqualität und seine verwendung
MA25266A1 (fr) Procede de production de fromage et de produits a base de fromage
WO2008073888A3 (en) Compositions of human lipids and methods of making and using same
SE8404545D0 (sv) Sett och anleggning for att framsstella mjolk med lag bakteriehalt
DK1364583T3 (da) Mælkeprodukter med reduceret gennemsnitlig partikelstörrelse
EA200970712A1 (ru) Новый питьевой йогурт и способ его производства
FI20055076A (fi) Vähäenergiainen, runsaasti kalsiumia sisältävä, rasvaton maitojuoma ja menetelmä sen valmistamiseksi
ATE240655T1 (de) Verfahren zur herstellung von sauermilchgetränken
PL2283732T3 (pl) Sposób wytwarzania frakcji kompozycji mlecznej
WO2007032459A8 (ja) 発酵乳の食感改良方法
FR2850534B1 (fr) Yoghourt de structure bimodale et procede de preparation
CA2574805C (en) Reduced-fat flavor components
WO2004075667A3 (en) Reduced fat and carbohydrate milk product and process for manufacturing such milk product
NZ608412A (en) Method to separate lipids from cheese whey and fat-free whey protein product formed thereby
KR970005076A (ko) 가공 치즈 제조를 위한 원료 물질로서의 산성화된 한외 여과 농축물
WO2004075666A3 (en) Reduced carbohydrate milk product and process for manufacturing such milk product
JP6002363B2 (ja) 濃縮乳およびその製造方法
WO2005046344A3 (en) Dairy product and process
DE60218654D1 (de) Lebensmittel
BRPI0412284A (pt) processo para a preparação de um produto de laticìnio modificado
ATE366049T1 (de) Buttermilchquark und verfahren zu dessen herstellung und weiterverarbeitung
ATE330485T1 (de) Verfahren zur hochdruckhomogenisierung einer milchemulsion
DK1101408T3 (da) Fremgangsmåde til fremstilling af en ost med lavt fedtindhold
DE60314810D1 (de) Verfahren und Vorrichtung zur Herstellung von Käse aus Milch

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties